Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor
drops out
-
Pfizer’s announcement that it will stop developing its oral weight-loss
drug gave shares of Wegovy maker Novo Nordisk and Zepbound maker Eli Lilly
a lift.
18 minutes ago
GREAT EXPECTATIONS in REALITY in DEED is but only too OBVIOUS. ... http://youtu.be/eHd8wa0b5J0
ReplyDelete